section name header

Evidence summaries

Betamethasone for Idiopathic Thrombocytopenic Purpura during Pregnancy

Betamethasone might possibly not be useful for treating idiopathic thrombocytopenic purpura during pregnancy, but the evidence is insufficient. Level of evidence: "D"

A Cochrane review [Abstract] 1 included 1 study with a total of 38 women (41 pregnancies). Only 26 women (28 pregnancies) were analysed.Betamethasone (1.5 mg/day) compared with no medication found no statistically significant difference in neonatal thrombocytopenia (RR) 1.12, 95% CI 0.62 to 2.05) and neonatal bleeding (RR 1.00, 95% CI 0.24 to 4.13). An intention-to-treat analysis which showed similar findings: RR 1.18, 95% CI 0.57 to 2.45 and RR 1.05, 95% CI 0.24 to 4.61, respectively. Maternal death, perinatal mortality, postpartum haemorrhage and neonatal intracranial haemorrhage were not studied by this RCT.

Comment: The quality of evidence is downgraded by study quality (inadequate or unclear allocation concealment), high attrition rate and imprecise results (few patients and wide confidence intervals). .

References

  • Martí-Carvajal AJ, Peña-Martí GE, Comunián-Carrasco G. Medical treatments for idiopathic thrombocytopenic purpura during pregnancy. Cochrane Database Syst Rev 2009 Oct 7;(4):CD007722. [PubMed]

Primary/Secondary Keywords